Journal articleCancer Chemother Pharmacol2017
A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent.
- Journal
- Cancer Chemother Pharmacol
- Published
- 12 July 2017
- Citations
- 10
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try